open access

Vol 62, No 5 (2011)
Review article
Published online: 2011-11-08
Submitted: 2013-02-15
Get Citation

Vascular endothelial growth factor (VEGF) — part 1: in physiology and pathophysiology

Dariusz Kajdaniuk, Bogdan Marek, Halina Borgiel-Marek, Beata Kos-Kudła
Endokrynologia Polska 2011;62(5):444-455.

open access

Vol 62, No 5 (2011)
Review article
Published online: 2011-11-08
Submitted: 2013-02-15

Abstract

Angiogenesis is an important component of many physiological processes, such as the female sexual cycle, placenta formation, the processes of growth and differentiation of tissues, and reparative processes including wound healing, fracture repair, and liver regeneration. The formation of new blood vessels during angiogenesis and vasculogenesis allows the growth and functioning of multicellular organisms. Pathological angiogenesis most commonly occurs in ischaemic, inflammatory and neoplastic diseases. Conditions in the pathogenesis of which angiogenesis plays an important role are sometimes labelled angiogenic diseases. To date, a number of pro-and anti-angiogenic factors have been defined. VEGF is the only specific mitogen for endothelial cells. It stimulates their growth and inhibits apoptosis, increases vascular permeability in many tissues, promotes vasculogenesis and angiogenesis. VEGF signalling activity in relation to the cell is dependent on having its specific membrane receptors (Flt-1, KDR, Flt-4). Angiogenesis plays a protective role in ischaemic heart disease and myocardial infarction. Angiogenesis extends life for patients after a stroke. Most of the facts about physiological angiogenesis are derived from studies into liver regeneration as a result of an acute injury or partial hepatectomy. Pathological hepatic angiogenesis occurs in the course of inflammation, fibrosis, hypoxia, and during tumourogenesis. There is interesting data relating to liver steatosis and obesity. (Pol J Endocrinol 2011; 62 (5): 444–455)

Abstract

Angiogenesis is an important component of many physiological processes, such as the female sexual cycle, placenta formation, the processes of growth and differentiation of tissues, and reparative processes including wound healing, fracture repair, and liver regeneration. The formation of new blood vessels during angiogenesis and vasculogenesis allows the growth and functioning of multicellular organisms. Pathological angiogenesis most commonly occurs in ischaemic, inflammatory and neoplastic diseases. Conditions in the pathogenesis of which angiogenesis plays an important role are sometimes labelled angiogenic diseases. To date, a number of pro-and anti-angiogenic factors have been defined. VEGF is the only specific mitogen for endothelial cells. It stimulates their growth and inhibits apoptosis, increases vascular permeability in many tissues, promotes vasculogenesis and angiogenesis. VEGF signalling activity in relation to the cell is dependent on having its specific membrane receptors (Flt-1, KDR, Flt-4). Angiogenesis plays a protective role in ischaemic heart disease and myocardial infarction. Angiogenesis extends life for patients after a stroke. Most of the facts about physiological angiogenesis are derived from studies into liver regeneration as a result of an acute injury or partial hepatectomy. Pathological hepatic angiogenesis occurs in the course of inflammation, fibrosis, hypoxia, and during tumourogenesis. There is interesting data relating to liver steatosis and obesity. (Pol J Endocrinol 2011; 62 (5): 444–455)
Get Citation

Keywords

VEGF; angiogenesis; physiology; pathophysiology; KDR; Flt-1; liver; cancer; neoplasm; growth factor

About this article
Title

Vascular endothelial growth factor (VEGF) — part 1: in physiology and pathophysiology

Journal

Endokrynologia Polska

Issue

Vol 62, No 5 (2011)

Pages

444-455

Published online

2011-11-08

Bibliographic record

Endokrynologia Polska 2011;62(5):444-455.

Keywords

VEGF
angiogenesis
physiology
pathophysiology
KDR
Flt-1
liver
cancer
neoplasm
growth factor

Authors

Dariusz Kajdaniuk
Bogdan Marek
Halina Borgiel-Marek
Beata Kos-Kudła

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl